RSV F-protein and use thereof

Details for Australian Patent Application No. 2007338383 (hide)

Owner Ruhr-Universitat Bochum Pevion Biotech Ltd.

Inventors Uberla, Klaus; Grunwald, Thomas

Agent Spruson & Ferguson

Pub. Number AU-A-2007338383

PCT Pub. Number WO2008/077527

Priority 10 2006 060 799.6 21.12.06 DE

Filing date 18 December 2007

Wipo publication date 3 July 2008

International Classifications

C12N 15/45 (2006.01) Mutation or genetic engineering

A61K 39/155 (2006.01) Medicinal preparations containing antigens or antibodies - Paramyxoviridae, e.g. parainfluenza virus

C07K 14/135 (2006.01) Peptides having more than 20 amino acids

C12N 15/85 (2006.01) Mutation or genetic engineering - for animal cells

C12N 15/861 (2006.01) Mutation or genetic engineering - Adenoviral vectors

Event Publications

30 July 2009 PCT application entered the National Phase

  PCT publication WO2008/077527 Priority application(s): WO2008/077527

18 February 2010 Alteration of Name

  The name of the has been altered to Ruhr-Universitat Bochum; Pevion Biotech AG 2008

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007338385-Synergistic therapeutic use of prothrombin complex concentrates with FVIII concentrates

2007338378-Use of polypeptides as coccidiostat and /or histomonastat